IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q3 2023 Holdings

Filed 2023-11-14 | 6 holdings | $113.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Omeros CorpNOTE 5.250% 2/1682143AG7$44.6M$72,979,00039.3%
Biora Inc.Note 7.250% 12/074319FAB3$28.0M$53,500,00024.6%
Biora Inc.COM NEW74319F305$23.7M10,929,76220.9%
Omeros CorpNOTE 6.250%11/1682143AE2$11.3M$11,005,0009.9%
Puma Biotechnology Inc(PBYI)COM74587V107$4.7M1,792,1144.2%
RVL Pharmaceuticals PLCSHSG6S41R101$1.3M14,600,4441.1%